核心蛋白质自然选择突变的影响与HBV生物合成中的HBeAg负状态相关
María Mercedes Elizalde1,2, Cecilia Graciela Giadans1,2, Rodolfo Héctor Campos2,3
1Facultad de Medicina, Departamento de Microbiología, Parasitología e Inmunología, Instituto de Investigaciones Biomédicas en Retrovirus y Sida (INBIRS), CONICET, Universidad de Buenos Aires, Buenos Aires, Argentina.
Journal of medical virology
|October 26, 2023
概括
在慢性乙型肝炎病毒 (HBV) 感染中,B型肝炎抗原 (HBeAg) 损失与核心蛋白质突变有关. 这些突变会影响病毒的复制和组合,影响疾病的进展.
科学领域:
- 病毒学 病毒学
- 肝病学 肝病学是一种肝病学.
- 分子生物学分子生物学
背景情况:
- 乙型肝炎抗原 (HBeAg) 损失意味着慢性乙型肝炎病毒 (HBV) 感染的晚期.
- 这一阶段的特点是病毒DNA减少,疾病进展风险降低.
- 在HBeAg损失期间HBV复制下调背后的机制仍然不清楚.
研究的目的:
- 研究B型肝炎核心蛋白 (HBc) 突变在HBeAg阴性慢性HBV感染中的作用.
- 了解HBc突变如何影响病毒复制和结构.
主要方法:
- 在HBeAg阴性与HBeAg阳性HBV序列 (亚基因型D1) 中分析HBc突变.
- 评估HBc突变对病毒结构,亚细胞局部化和复制能力的影响.
- 对共闭环形DNA (cccDNA) 循环利用的影响的评估.
主要成果:
- 与HBeAg阳性患者相比,HBeAg阴性患者的HBc序列中的突变率更高.
- 确定了22种氨基酸,在HBeAg阴性序列中突变频率增加.
- 证明HBc突变能够调节蛋白质定位,囊组合和病毒复制.
结论:
- 与HBeAg阴性状态相关的HBc突变在调节HBV复制方面发挥着重要作用.
- 这些突变影响HBV生命周期的多个阶段.
- 了解这些突变为治疗慢性HBV感染提供了洞察力.
相关概念视频
Hepatic Drug Clearance: Effect of Protein Binding
216
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
216
In-vitro Mutagenesis
14.0K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
14.0K
Hepatic Drug Excretion: Influencing Factors
134
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
134
Viral Mutations
32.4K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.4K
Mutations
83.3K
Overview
83.3K
Rab Proteins
4.0K
Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
4.0K


